Anti-Tumor Effect in Human Lung Cancer by a Combination Treatment of Novel Histone Deacetylase Inhibitors: SL142 or SL325 and Retinoic Acids

• Shaoteng Han,

  Affiliations Department of Gastroenterological Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan, Department of Hepatobiliary Surgery, Shengjing Hospital, China Medical University, Shenyang, China

  ⨯
• Takuya Fukazawa ,

  * E-mail: FukazawaT@aol.com

  Affiliation Department of General Surgery, Kawasaki Medical School, Okayama, Japan

  ⨯
• Tomoki Yamatsuji,

  Affiliation Department of General Surgery, Kawasaki Medical School, Okayama, Japan

  ⨯
• Junji Matsuoka,

  Affiliation Department of Gastroenterological Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

  ⨯
• Hiroyuki Miyachi,

  Affiliation Division of Pharmaceutical Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

  ⨯
• Yutaka Maeda,

  Affiliation Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America

  ⨯
• Mary Durbin,

  Affiliation Department of Ecology and Evolutionary Biology, University of California Irvine, Irvine, California, United States of America

  ⨯
• Yoshio Naomoto

  Affiliation Department of General Surgery, Kawasaki Medical School, Okayama, Japan

  ⨯